Tecarfarin Completed Phase 2 Trials for Nonvalvular Atrial Fibrillation Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00431782Study of a New Anticoagulant Drug in Patients With Atrial Fibrillation